BPCE
Bank Pictet & Cie (Europe) Portfolio holdings
AUM
$4.68B
This Quarter Return
+1.24%
1 Year Return
+16.47%
3 Year Return
+101.24%
5 Year Return
+155.05%
10 Year Return
+381.72%
AUM
$2.7B
AUM Growth
+$2.7B
(-5.8%)
Cap. Flow
-$166M
Cap. Flow
% of AUM
-6.16%
Top 10 Holdings %
Top 10 Hldgs %
42.72%
Holding
179
New
10
Increased
47
Reduced
74
Closed
11
Top Buys
| 1 |
NVIDIA
NVDA
|
$51.1M |
| 2 |
Fidelity National Information Services
FIS
|
$34.2M |
| 3 |
Salesforce
CRM
|
$18.8M |
| 4 |
McDonald's
MCD
|
$14.3M |
| 5 |
Visa
V
|
$14.2M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$225M |
| 2 |
Citigroup
C
|
$30M |
| 3 |
Cognizant
CTSH
|
$14.7M |
| 4 |
Boston Scientific
BSX
|
$10.4M |
| 5 |
Microsoft
MSFT
|
$7.77M |
Sector Composition
| 1 | Healthcare | 24.47% |
| 2 | Technology | 20.73% |
| 3 | Consumer Discretionary | 14.6% |
| 4 | Communication Services | 14.36% |
| 5 | Financials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Logitech
LOGI
$15.3B
| $1.16M | 0.04% | 12,938 | – | – |
|
102
Moderna
MRNA
$9.37B
| $1.1M | 0.04% | 2,854 -181 | -6% | -$69.6K |
|
103
Bristol-Myers Squibb
BMY
$96B
| $1.1M | 0.04% | 18,539 -363 | -2% | -$21.5K |
|
104
Biogen
BIIB
$19.4B
| $1.08M | 0.04% | 3,814 +1,545 | +68% | +$437K |
|
105
Palo Alto Networks
PANW
$127B
| $1.06M | 0.04% | 2,221 -254 | -10% | -$122K |
|
106
TaskUs
TASK
$1.57B
| $1.02M | 0.04% | +15,328 | New | +$1.02M |
|
107
Guardant Health
GH
$8.41B
| $996K | 0.04% | 7,967 +339 | +4% | +$42.4K |
|
108
Verizon
VZ
$186B
| $978K | 0.04% | 18,100 -1,455 | -7% | -$78.6K |
|
|
GB
109
DELISTED
Global Blue Group Holding
GB
| $831K | 0.03% | +128,571 | New | +$831K |
|
110
Gilead Sciences
GILD
$140B
| $805K | 0.03% | 11,525 | – | – |
|
111
Intel
INTC
$107B
| $805K | 0.03% | 15,100 | – | – |
|
112
Cisco
CSCO
$274B
| $800K | 0.03% | 14,706 | – | – |
|
113
Dropbox
DBX
$7.84B
| $726K | 0.03% | 24,848 +11,469 | +86% | +$335K |
|
114
Natera
NTRA
$23.1B
| $721K | 0.03% | 6,469 -599 | -8% | -$66.8K |
|
115
DexCom
DXCM
$29.5B
| $706K | 0.03% | 1,291 -4,457 | -78% | -$2.44M |
|
116
Enbridge
ENB
$105B
| $685K | 0.03% | 17,200 | – | – |
|
117
Xylem
XYL
$34.5B
| $685K | 0.03% | 5,541 +1,178 | +27% | +$146K |
|
118
Walmart
WMT
$774B
| $646K | 0.02% | 4,635 +535 | +13% | +$74.6K |
|
119
TJX Companies
TJX
$152B
| $643K | 0.02% | 9,738 | – | – |
|
120
Netflix
NFLX
$513B
| $638K | 0.02% | 1,045 +165 | +19% | +$101K |
|
121
Stryker
SYK
$150B
| $631K | 0.02% | 2,394 -743 | -24% | -$196K |
|
122
Insulet
PODD
$23.9B
| $598K | 0.02% | 2,104 -196 | -9% | -$55.7K |
|
123
iShares MSCI World ETF
URTH
$5.61B
| $590K | 0.02% | 4,664 | – | – |
|
124
Tandem Diabetes Care
TNDM
$845M
| $587K | 0.02% | 4,918 -473 | -9% | -$56.5K |
|
125
Castle Biosciences
CSTL
$696M
| $574K | 0.02% | 8,624 -762 | -8% | -$50.7K |
|